Form4insider filings, from the source

Company · CIK 0001812364 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq

Relay Therapeutics, Inc. · RLAY

Insider activity reported against this company. All insider holders · On EDGAR ↗

1M3M6M1Y2YAll datashares as filed — not split-adjusted
Open-market buys & salesbuys $0 · 0sales $126.5M · 16net −$126.5M
$100k$100k$10M$10M$1B$1BbuyssalesJun 21Jul 4Jul 17Jul 31Aug 13Aug 26Sep 9

Reported at this company — common stock

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Sep 8, 2026 SForm 4 →Sep 9, 4:17 pm EDTDonald A BergstromPresident, R&D8,530$18.97$161,814399,130−2.09%10b5-1
Sep 8, 2026 SForm 4 →Sep 9, 4:15 pm EDTThomas CatinazzoChief Financial Officer17,717$18.94$335,560122,851−12.6%10b5-1
Sep 8, 2026 SForm 4 →Sep 9, 4:12 pm EDTSanjiv PatelPresident and CEO, Director48,199$18.94$912,889519,500−8.49%10b5-1
Aug 26, 2026 SForm 4 →Aug 28, 4:43 pm EDTPeter RahmerSee remarks4,508$20.03$90,295223,657−1.98%10b5-1
Aug 25, 2026 SForm 4 →Aug 28, 9:01 am EDTSVF Pauling (Cayman) Ltd +210% Owner6,000,000$19.40$116,400,00021,904,963−21.5% late
Aug 17, 2026 SForm 4 →Aug 18, 4:17 pm EDTSanjiv PatelPresident and CEO, Director48,199$20.33$979,886567,699−7.83%10b5-1
Aug 14, 2026 SForm 4 →Aug 18, 4:16 pm EDTThomas CatinazzoChief Financial Officer17,717$19.74$349,734140,568−11.2%10b5-1
Jul 28, 2026 SForm 4 →Jul 30, 4:13 pm EDTThomas CatinazzoChief Financial Officer1,459$18.61$27,152158,285−0.91%
Jul 28, 2026 SForm 4 →Jul 30, 4:13 pm EDTPeter RahmerSee remarks748$18.61$13,920228,165−0.33%
Jul 28, 2026 SForm 4 →Jul 30, 4:12 pm EDTDonald A BergstromPresident, R&D2,237$18.61$41,631407,660−0.55%
Jul 7, 2026 SForm 4 →Jul 8, 5:08 pm EDTSanjiv PatelPresident and CEO, Director48,199$19.58$943,736615,898−7.26%10b5-1
Jul 6, 2026 SForm 4 →Jul 8, 5:11 pm EDTDonald A BergstromPresident, R&D8,660$18.71$162,029409,897−2.07%10b5-1
Jul 6, 2026 SForm 4 →Jul 8, 5:07 pm EDTThomas CatinazzoChief Financial Officer17,717$18.69$331,131159,744−9.98%10b5-1
Jun 30, 2026 AForm 4 →Jul 8, 5:08 pm EDTSanjiv PatelPresident and CEO, Director3,056$6.95$21,239664,097—10b5-1 late
Jun 30, 2026 AForm 4 →Jul 2, 4:12 pm EDTPeter RahmerSee remarks3,056$6.95$21,239228,913—10b5-1
Jun 30, 2026 SForm 4 →Jul 2, 4:12 pm EDTPeter RahmerSee remarks50,000$19.09$954,500225,857−18.1%10b5-1
Jun 22, 2026 MForm 4 →Jun 24, 4:09 pm EDTThomas CatinazzoChief Financial Officer169,446$4.93$834,669229,021—10b5-1
Jun 22, 2026 SForm 4 →Jun 24, 4:09 pm EDTThomas CatinazzoChief Financial Officer187,163$16.97$3,176,865177,461−51.3%10b5-1
Jun 22, 2026 SForm 4 →Jun 24, 4:09 pm EDTDonald A BergstromPresident, R&D93,456$16.94$1,583,145418,557−18.3%10b5-1
Jun 22, 2026 MForm 4 →Jun 24, 4:09 pm EDTDonald A BergstromPresident, R&D93,456$4.12$385,039512,013—10b5-1

Reported at this company — derivatives (options, RSUs, warrants)

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Jun 22, 2026 MForm 4 →Jun 24, 4:09 pm EDTThomas CatinazzoChief Financial Officer169,446——223,440—10b5-1
Jun 22, 2026 MForm 4 →Jun 24, 4:09 pm EDTDonald A BergstromPresident, R&D93,456——0—10b5-1
Jun 9, 2026 AForm 4 →Jun 10, 4:30 pm EDTClaire MazumdarDirector32,947——32,947—
Jun 9, 2026 AForm 4 →Jun 10, 4:30 pm EDTHabib J DableDirector32,947——32,947—
Jun 9, 2026 AForm 4 →Jun 10, 4:30 pm EDTLinda A HillDirector32,947——32,947—
Jun 9, 2026 AForm 4 →Jun 10, 4:30 pm EDTAlexis BorisyDirector32,947——32,947—
Jun 9, 2026 AForm 4 →Jun 10, 4:30 pm EDTDouglas S IngramDirector32,947——32,947—
Jun 9, 2026 AForm 4 →Jun 10, 4:30 pm EDTMark MurckoDirector32,947——32,947—
Jun 9, 2026 AForm 4 →Jun 10, 4:30 pm EDTLonnel CoatsDirector32,947——32,947—